0001662579-23-000107.txt : 20231003
0001662579-23-000107.hdr.sgml : 20231003
20231003162638
ACCESSION NUMBER: 0001662579-23-000107
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231002
FILED AS OF DATE: 20231003
DATE AS OF CHANGE: 20231003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GROGAN DONNA ROY
CENTRAL INDEX KEY: 0001788455
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39567
FILM NUMBER: 231304116
MAIL ADDRESS:
STREET 1: 1133 OLD QUEEN ANNE ROAD
CITY: CHATHAM
STATE: MA
ZIP: 02633
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: C4 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662579
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475617627
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 120
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (617) 231-0700
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 120
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
wk-form4_1696364777.xml
FORM 4
X0508
4
2023-10-02
0
0001662579
C4 Therapeutics, Inc.
CCCC
0001788455
GROGAN DONNA ROY
C/O C4 THERAPEUTICS, INC.
490 ARSENAL WAY #120
WATERTOWN
MA
02472
1
0
0
0
0
Common Stock
2023-10-02
4
A
0
8089
1.70
A
19827
D
These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 2, 2023.
/s/ Jolie M. Siegel, Attorney-in-Fact
2023-10-03